Significant Ownership of CITADEL ADVISORS LLC

Notable people
Ken Griffin
Signature - Title
/s/ Seth Levy - Seth Levy, Authorized Signatory
Location
Miami, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by CITADEL ADVISORS LLC.

Notify me when CITADEL ADVISORS LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of CITADEL ADVISORS LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BCTX BriaCell Therapeutics Corp. Common Shares, no par value per share (the "Shares") 10% $5,119,574 717,198 Kenneth Griffin 15 Jan 2026
FLYY Spirit Aviation Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 9.9% $14,461,405 1,624,877 Kenneth Griffin 29 Apr 2025
ASST ASSET ENTITIES INC. Class B Common Stock, par value $0.0001 per share (the "Shares") 8.1% $4,287,283 1,268,427 Kenneth Griffin 18 Aug 2025
LXEO Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") 7.4% $40,851,767 +$1,219,315 5,498,219 +3.1% Kenneth Griffin 31 Dec 2025
FGNX FG Nexus Inc. Common Stock, par value $0.001 per share (the "Shares") 6.6% $61,435,465 2,501,444 Kenneth Griffin 05 Sep 2025
SPRB Spruce Biosciences, Inc. Common Stock, par value $0.0001 per share (the "Shares") 6.5% $5,707,852 -$3,228,541 70,035 -36% Kenneth Griffin 31 Dec 2025
DBVT DBV Technologies S.A. Ordinary shares, nominal value EUR0.10 per share (the "Shares") 6.4% $78,425,733 9,194,107 Kenneth Griffin 07 Apr 2025
BOLD Boundless Bio, Inc. Common stock, par value $0.0001 per share (the "Shares") 6.4% $1,763,067 1,433,388 Kenneth Griffin 26 Nov 2025
ASST Strive, Inc. Class A Common Stock, $0.001 par value per share (the "Shares") 6.3% $44,647,773 +$4,444,316 46,028,632 +11% Kenneth Griffin 31 Dec 2025
NA Nano Labs Ltd Class A ordinary shares, par value US$0.002 per share (the "Shares") 6.2% $7,347,089 -$3,916,226 1,360,572 -35% Kenneth Griffin 30 Sep 2025
ALLO Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 6.1% $15,091,828 13,346,151 Kenneth Griffin 09 Jul 2025
JUPGD Atlas Critical Minerals Corporation Common stock, par value $0.001 per share (the "Shares") 6% $3,883,745 298,520 Kenneth Griffin 12 Jan 2026
ATLX Atlas Lithium Corporation Common Stock, par value $0.001 per share (the "Shares") 5.9% $6,636,573 1,557,881 Kenneth Griffin 08 Dec 2025
AARD Aardvark Therapeutics, Inc. Common Stock, par value $0.00001 per share (the "Shares") 5.6% $13,635,659 1,192,971 Kenneth Griffin 14 Feb 2025
SPAI Safe Pro Group Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.5% $6,960,168 -$645,499 1,200,029 -8.5% Kenneth Griffin 31 Dec 2025
ACRV Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") 5.5% $3,116,579 +$326,709 1,721,867 +12% Kenneth Griffin 14 Nov 2025
HOND HCM II Acquisition Corp. Class A Ordinary Shares, par value $0.0001 per share (the "Shares") 5.4% $14,310,259 1,233,643 Kenneth Griffin 23 Sep 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (the "Shares") 5.3% $12,405,011 980,610 Kenneth Griffin 04 Nov 2025
SNCY Sun Country Airlines Holdings, Inc. Common Stock, par value $0.01 per share (the "Shares") 5.1% $38,651,439 -$7,352,153 2,685,993 -16% Kenneth Griffin 31 Dec 2025
PLRX PLIANT THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (the "Shares") 5% $3,711,402 +$5,414 3,042,133 +0.15% Kenneth Griffin 02 Feb 2026
QUBT Quantum Computing Inc. Common stock, par value $0.0001 per share (the "Shares") 4.9% $146,902,081 9,244,939 Kenneth Griffin 25 Sep 2025
TARA Protara Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 4.7% $7,031,811 1,627,734 Kenneth Griffin 31 Dec 2024
DFDV DeFi Development Corp. Common Stock, par value $0.00001 per share (the "Shares") 4.5% $19,964,392 1,315,654 Kenneth Griffin 14 Oct 2025
SLRN ACELYRIN, Inc. Common Stock, par value $0.00001 per share (the "Shares") 4.2% $10,335,933 4,218,748 Kenneth Griffin 31 Dec 2024
OPAD Offerpad Solutions Inc. Class A common stock, $0.0001 par value per share (the "Shares") 4.2% $2,346,543 1,971,885 Kenneth Griffin 13 Jan 2026
TERN Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares") 4.1% $10,118,696 3,465,307 Kenneth Griffin 31 Dec 2024
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share (the "Shares") 4.1% $6,003,741 2,900,358 Kenneth Griffin 30 Sep 2025
SPHR Sphere Entertainment Co. Class A Common Stock 3.9% $29,521,356 1,115,276 Kenneth Griffin 31 Mar 2025
KRRO Korro Bio, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.9% $6,163,449 369,733 Citadel Advisors LLC 31 Dec 2024
LITS Lite Strategy, Inc. Common Stock, par value $0.00000002 per share (the "Shares") 3.9% $2,078,156 -$2,628,382 1,433,211 -56% Kenneth Griffin 31 Dec 2025
DBV Technologies S.A. Ordinary shares, nominal value EUR0.10 per share (the "Shares") 3.5% 8,146,510 Kenneth Griffin 31 Dec 2025
ALHC Alignment Healthcare, Inc. Common Stock, par value $0.001 per share (the "Shares") 3.4% $117,229,222 -$66,136,407 6,718,007 -36% Kenneth Griffin 30 Sep 2025
CGEM Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Shares") 3.4% $11,794,219 -$6,049,899 1,988,907 -34% Kenneth Griffin 30 Sep 2025
CABA Cabaletta Bio, Inc. Common stock, par value $0.00001 per share (the "Shares") 3.4% $7,371,644 -$3,903,787 3,150,275 -35% Kenneth Griffin 30 Sep 2025
DGXX DIGI POWER X INC. Subordinate Voting Shares, with no par value per share (the "Shares") 3.4% $3,474,120 1,517,083 Kenneth Griffin 10 Oct 2025
BBOT BridgeBio Oncology Therapeutics, Inc. Class A ordinary share, par value $0.0001 per share (the "Shares") 3.2% $29,391,684 2,538,142 Kenneth Griffin 30 Sep 2025
AREC American Resources Corporation Class A common stock, par value $0.0001 per share (the "Shares") 3.2% $10,633,455 -$22,121,280 3,202,848 -68% Kenneth Griffin 31 Dec 2025
UWMC UWM Holdings Corporation Class A Common Stock, par value $0.0001 per share (the "Shares") 2.8% $23,790,515 -$32,633,457 5,584,628 -58% Kenneth Griffin 30 Jun 2025
BKKT Bakkt Holdings, Inc. Class A Common Stock, par value $0.0001 per share (the "Shares") 2.7% $14,332,982 -$30,063,482 425,943 -68% Kenneth Griffin 30 Sep 2025
FVR FrontView REIT, Inc. Common Stock, $0.01 par value 2.4% $4,918,822 408,540 Kenneth Griffin 31 Mar 2025
ADT ADT Inc. Common stock, par value $0.01 per share (the "Shares") 2.2% $146,702,447 -$222,018,720 17,464,577 -60% Kenneth Griffin 30 Jun 2025
IMSR TERRESTRIAL ENERGY INC. Common stock, par value $0.0001 per share (the "Shares") 2.2% $24,811,883 2,303,796 Kenneth Griffin 31 Dec 2025
VTYX Ventyx Biosciences, Inc. Common Stock, par value $0.0001 per share 2% $1,776,097 1,409,601 Kenneth Griffin 31 Mar 2025
INSP Inspire Medical Systems, Inc. Common Stock, par value $0.001 per share (the "Shares") 1.8% $50,085,615 -$112,653,375 527,217 -69% Kenneth Griffin 31 Dec 2025
CMPS COMPASS Pathways plc Ordinary Shares, par value of GBP 0.008 per share (the "Shares"), each represented by one American Depositary Share 1.7% $4,397,992 1,166,576 Kenneth Griffin 31 Dec 2024
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share (the "Shares") 1.7% $700,612 223,125 Kenneth Griffin 31 Dec 2025
NB NioCorp Developments Ltd. Common Shares, without par value (the "Shares") 0.4% $3,381,881 -$49,573,450 507,790 -94% Kenneth Griffin 31 Dec 2025
ARVN ARVINAS, INC. Common stock, par value $0.001 per share (the "Shares") 0.4% $2,251,350 -$27,399,315 264,243 -92% Kenneth Griffin 30 Sep 2025
ALTS ALT5 Sigma Corporation Common Stock, par value $0.001 per share (the "Shares") 0.2% $1,760,642 282,607 Kenneth Griffin 12 Aug 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 (the "Shares") 0% $1,250 -$367,360 3,732 -100% Kenneth Griffin 30 Sep 2025
HE HAWAIIAN ELECTRIC INDUSTRIES INC Common Stock, Without Par Value (the "Shares") 0% $0 0 Citadel Advisors LLC 31 Dec 2024
LYRA Lyra Therapeutics, Inc. Common Stock, $0.001 par value per share (the "Shares") 0% $0 0 Citadel Advisors LLC 31 Dec 2024
RZLV Rezolve AI plc Ordinary Shares, par value (GBP)0.0001 per share (the "Shares") 0% $0 -$57,014,164 0 -100% Citadel Advisors LLC 31 Dec 2025
CBNA Chain Bridge Bancorp, Inc. Class A common stock, par value $0.01 per share 0% $0 0 Citadel Advisors LLC 31 Mar 2025

Schedules 13D/G Reported by CITADEL ADVISORS LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.